CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- 4 Open-market buy Watanabe Todd Franklin bought 6,038 shares at an average $3.52 ($21,250)
- 4 Open-market sale Burnett Patrick sold 16,023 shares at $10.14 ($162,515)
- 4 Planned sale Matsuda Masaru sold 1,775 shares at $9.68 ($17,190)
- 4 Open-market sale Burnett Patrick sold 69,226 shares at an average $10.29 ($712,621)
- 4 Open-market sale Director sold 8,687 shares at $10.85 ($94,238)
- 4 Planned sale Matsuda Masaru sold 5,015 shares at $8.68 ($43,551)
- 4 Planned sale Watanabe Todd Franklin sold 13,871 shares at $8.68 ($120,459)
- 4 Planned sale Director sold 10,000 shares at $8.65 ($86,541)
- 4 Planned sale Burnett Patrick sold 15,441 shares at $8.68 ($134,093)
- 4 Planned sale Director sold 10,000 shares at $9.26 ($92,616)
- 4 Planned sale SVP Chief Commercial Officer sold 3,725 shares at $10.01 ($37,295)
- 4 Open-market sale Chief Financial Officer sold 11,626 shares at $9.48 ($110,264)
- 4 Planned sale Director sold 10,000 shares at $10.77 ($107,695)
- 4 Planned sale Burnett Patrick sold 1,728 shares at $8.29 ($14,318)
- 4 Planned sale Matsuda Masaru sold 5,220 shares at $9.02 ($47,064)
- 4 Planned sale Burnett Patrick sold 13,206 shares at $9.02 ($119,106)
- 4 Planned sale Watanabe Todd Franklin sold 14,487 shares at $9.02 ($130,648)
- 4 Planned sale Director sold 10,000 shares at $9.87 ($98,696)
- 4 Planned sale Director sold 10,000 shares at $9.31 ($93,141)
- 4 Grant or award Director acquired 10,139 shares (grant or award)
Page 8 of 23 · 452 filings